MedTrace Logo

White Tea for Prevention of Chemotherapy Induced Mucositis

NCT04440930 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2023-09-05

No results posted yet for this study

Summary

The aim of this study is to determine the effectiveness of mouthwash with white tea in the prevention of paclitaxel induced oral mucositis in women with breast cancer.

Conditions

  • Oral Mucositis

Interventions

OTHER

White tea

Mouthwash with white tea five to six times a day for nine weeks

OTHER

Salt water with soda

Mouthwash with salt water and soda eight to ten times a day for nine weeks

Sponsors & Collaborators

  • Vejle Hospital

    lead OTHER

Principal Investigators

  • Erik H Jakobsen, MD · Vejle Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-02
Primary Completion
2023-03-28
Completion
2023-04-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04440930 on ClinicalTrials.gov